Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Izzy who wrote (4198)	5/4/1998 3:33:00 PM
From: Steve Fancy	Read Replies (1) of 6136

Isaac, thanks for providing the info...now who would jump all over you...just give me their address.<g> I thought I heard CNBC state the ENMD product is about a year away from human testing. I also thought I heard the effective rate was near 100%...someone please correct me if I'm wrong. Am I to understand the AGPH product is based on the same technology as ENMD's? Did AGPH tell you when they might release further information? If I were to guess, it's not the lack of bragging that's holding the stock back, it's the lack of news of any kind. What would be considered a normal time lapse between the suggestion of a drug entering a new phase of trials and the release information regarding the previous phase? I have no idea. I find the silence disturbing, but as I've stated before, am not familiar with standard practice in these situations. sf

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next